See You at Women in Ophthalmology – Amelia Island! 🌴 We’re ready to talk all things Ocular Surface Disease! Want to reach us before the event? https://brnw.ch/21wUy7c #WomenInOphthalmology #CAM360AG #DryEye #EarlyIntervention #BioTissueOcular
BioTissue Ocular
Biotechnology Research
Miami, Florida 6,882 followers
Trailblazing Biologics in Ophthalmics
About us
BioTissue Holdings, Inc. is the pioneer and leader in regenerative medicine for ocular surface disease and injury, as well as ocular hygiene solutions for eye care professionals. Established in 1997, BioTissue serves an unmet need for better surgical and therapeutic alternatives for helping eye care professionals manage ocular surface conditions, such as keratitis, recurrent corneal erosions, conjunctivochalasis (CCH) also known as mechanical dry eye, pterygium and severe dry eye. Eye care professionals understand that good medicine is based on good science. BioTissue prides itself on developing products that meet the highest clinical standards, are based on quality research and scientific data, and provide innovative solutions for the management of a range of ocular surface and lid margin diseases. BioTissue adheres to the FDA tissue and medical device guidelines. BioTissue offers the only commercially available amniotic membrane that preserves the native integrity, activity, and function exhibited by the tissue in utero for ocular surface wound repair and wound healing. Our proprietary processing and preservation method retains vital cytokines and growth factors which facilitate healing mechanisms such as: • Anti-inflammatory • Anti-scarring • Anti-angiogenic • Pain reduction • Promotion of epithelial healing
- Website
-
https://biotissue.com/products/biotissue-ocular/
External link for BioTissue Ocular
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Miami, Florida
- Type
- Privately Held
- Founded
- 1997
Locations
-
Primary
7300 Corporate Center Dr
Suite 700
Miami, Florida 33126, US
-
7000 SW 97 Avenue
Suite 211
Miami, Florida 33173, US
Employees at BioTissue Ocular
-
Norbert Lam
Direct Sales Representative - BioTissue - Ocular, Regenerative Therapy For Cornea Inclusive Ocular Surface Disease
-
David Cormanick
Ophthalmic Sales Account Manager
-
Dion Maclin
Manager, Business Development at BioTissue
-
Matthew Kohl
Experienced Medical Device Sales Representative
Updates
-
💁Who doesn’t want to be ringless & hydrated in the summer? Sounds convenient... just like CAM360 AG™! A shelf-stable* Cryopreserved Amniotic Membrane. https://lnkd.in/g8Z2kC47 #CAM360AG #BioTissueOcular *Please refer to our Product Insert for storage information
-
-
Knowing where your tissue comes from matters... Our birth tissue is donated from healthy moms in the U.S., and through our partnership with Sharing Miracles®, each step is carefully managed to meet FDA & AATB standards. This process helps ensure the tissue is safe for clinical use. Learn more about procurement here: https://brnw.ch/21wUp9h #SharingMiracles #BioTissueOcular #RegenerativeHealing
-
📢 Big news in Ocular Surface Disease care. Drs. Milner, Doll, Schultze, and Whitley emphasize the importance of earlier intervention in managing Ocular Surface Diseases (OSDs) to improve outcomes & prevent disease progression. They highlight Cryopreserved Amniotic Membranes (CAMs), like Prokera® & CAM360 AmnioGraft™, and their role in real-world cases, including Neurotrophic Keratitis (NK). Why? Because early intervention may help your patients have better outcomes. 🚨 Our new Educational Supplement is out now! Download it here: https://lnkd.in/egRp5nFi #EarlyIntervention #CAM360AG #Prokera #NKAwareness #BioTissueOcular 1. Milner, M.S., Doll, T., Schultze, R., Whitley, W. Evolving Standards of Care in Ocular Surface Disease: Expert Discussion & Clinical Protocols. BioTissue Holdings Inc.; 2025. US-CAM360-0129.
-
-
Don’t blink — WIO is almost here. We’re proud to stand with the women driving ophthalmology forward. Come see us there! #WIO2025 #WomenInOphthalmology #CAM360AG #Prokera #BioTissueOcular
-
BioTissue Ocular reposted this
Not all ocular surface conditions are the same—and neither are their treatments. 🔹 CAM360 AmnioGraft™ was developed to optimize comfort allowing for early intervention in mild to moderate cases of Dry Eye Disease (DED), Superficial Punctate Keratitis (SPK), and Stage 1 Neurotrophic Keratitis (NK). 🔹 Prokera® is recommended for more advanced cases of Ocular Surface Disease—when inflammation & damage are more severe. Looking to match the right solution to the right patient? 👉 Learn more, and connect with your BioTissue rep today: https://lnkd.in/eTgkJpYi #CAM360AG #Prokera #OcularSurfaceDisease #EarlyIntervention #BioTissueOcular #RegenerativeHealing *posted on behalf of ASOA Gold Strategic Business Partner BioTissue
-
Did you know that millions of Americans suffer from Dry Eye Disease and don’t even know it? ¹ July is Dry Eye Awareness Month, and we’re focusing on the power of early intervention with Cryopreserved Amniotic Membrane to help improve signs & symptoms of Dry Eye Disease.⁶ Let’s continue to pave the way in early detection & intervention. #DryEyeAwarenessMonth #CAM360AG #BioTissueOcular #EarlyIntervention #OcularSurfaceDisease #Prokera 1. Farrand, K. F., Fridman, M., Stillman, I. Ö., & Schaumberg, D. A. (2017). Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. American Journal of Ophthalmology, 182, 90–98. https://lnkd.in/eRiAAasN 2. UpToDate. (n.d.). Dry eye disease. Retrieved July 10, 2025, from https://lnkd.in/eZHRNmGJ 3. Eyes On Eyecare. (2023). 2023 Dry Eye Report. Retrieved from https://lnkd.in/eFzh3mNX 4. Eyesurgeryguide.org. (n.d.). Prevalence of dry eye disease in the US: A growing concern. Retrieved July 10, 2025, from https://lnkd.in/em-BpazN 5. Data on file.
-
Not all heroes wear capes… Some wear gloves & apply Cryopreserved Amniotic Membrane. 🦸♂️👁️ We built AI action figures of our physicians—equipped with everything they need to apply CAM360 AmnioGraft™ or Prokera®. From forceps to clinical confidence, these are the real MVPs of Ocular Surface Disease. #CAM360AG #DryEyeDisease #RegenerativeHealing
-
For patients, early symptoms can go unnoticed, and most signs are easy to miss. This one isn’t. CAM360 AG™ gives you the opportunity for early intervention in Dry Eye, SPK, and NK before symptoms escalate. Now’s the time to act: biotissue.com/ocular #CAM360AG #EarlyIntervention #BioTissueOcular
-
Now you know... AmnioGraft® is an option for your patients undergoing Pterygium Surgery. Speak with our Team before your next case: biotissue.com/ocular #AmnioGraft #TissueTuck #PterygiumSurgery #BioTissueOcular #RegenerativeHealing